Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-13-000019
Filing Date
2013-08-14
Accepted
2013-08-14 17:29:32
Documents
13
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-063013.htm 10-Q 441881
2 CERTIFICATE OF AMENDMENT ex_3-13.htm EX-3.13 6814
3 LICENSE AGREEMENT AMAG PHARMACEUTICALS ex_10-16.htm EX-10.16 544562
4 CEO CERTIFICATION ex_31-1.htm EX-31.1 16175
5 CFO CERTIFICATION ex_31-2.htm EX-31.2 16256
6 CEO CERTIFICATION ex_32-1.htm EX-32.1 5998
7 CFO CERTIFICATION ex_32-2.htm EX-32.2 6194
  Complete submission text file 0000318306-13-000019.txt   4374512

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE REPORT accp-20130630.xml EX-101.INS 316961
9 XBRL TAXONOMY SCHEMA accp-20130630.xsd EX-101.SCH 15116
10 XBRL TAXONOMY CALCULATION LINKBASE accp-20130630_cal.xml EX-101.CAL 37120
11 XBRL TAXONOMY DEFINITION LINKBASE accp-20130630_def.xml EX-101.DEF 89644
12 XBRL TAXONOMY LABEL LINKBASE accp-20130630_lab.xml EX-101.LAB 234977
13 XBRL TAXONOMY PRESENTATION LINKBASE accp-20130630_pre.xml EX-101.PRE 156373
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 131038014
SIC: 2834 Pharmaceutical Preparations